Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis
about
Impaired spermatogenesis and fertility in mice carrying a mutation in the Spink2 gene expressed predominantly in testesGlobal gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma markerHepatitis C Virus and Nonliver Solid Cancers: Is There an Association between HCV and Cancers of the Pancreas, Thyroid, Kidney, Oral Cavity, Breast, Lung, and Gastrointestinal Tract?Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system.IL-17A G197A gene polymorphism contributes to susceptibility for liver cirrhosis development from patients with chronic hepatitis B infection in Chinese populationCombined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancerMolecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differencesTumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.Biomarker development, from bench to bedside.Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis.Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer.Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma.SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence.
P2860
Q28593778-6EA54FB9-FAF3-4829-AD4B-599D44B066D1Q31113966-B3C256CD-0686-4E9D-BFC0-318263DE8B70Q33696523-FC3A2F90-7F59-4694-9C56-C02A278B606CQ34588956-F602093A-E8EA-4DB3-A49B-056C6F1BA653Q35958731-D7016FAF-15B8-4DB6-B0B5-0C4CFC4EB225Q36038766-FA5CC170-24ED-4660-B043-1A9B575B8930Q36197335-D49AA1EA-7BA8-4013-849B-2A386F8ABB65Q36454775-5EC40182-738E-4DC1-A6D8-00D8942852FAQ37810431-928F59B3-15B4-4DC4-B13F-BBB90CFF759BQ38569348-87A2EF48-E6ED-46AE-8E1B-8A9FB1D97072Q39449718-0BC52478-C9A8-4EA4-80F2-D22813F6C774Q42748239-A45FA6D0-F200-409D-8F6A-E63A7890C6C5Q43544108-91F0144A-31B2-4F25-995E-84BA7980CD9BQ48030483-AF39BE65-F2C5-41EF-8629-2F32ECF33A9A
P2860
Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@ast
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@en
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@nl
type
label
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@ast
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@en
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@nl
prefLabel
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@ast
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@en
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@nl
P2093
P2860
P3181
P356
P1433
P1476
Hepatitis B and Hepatitis C Vi ...... e Protease-Dependent Apoptosis
@en
P2093
Jason Lamontagne
Mark Pinkerton
Timothy M Block
Xuanyong Lu
P2860
P304
P3181
P356
10.1128/JVI.01249-09
P577
2010-01-01T00:00:00Z